Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoyong Sanjie Decoction is a traditional Chinese medicine (TCM) herbal compound formula used clinically, particularly in China, for the treatment of inflammatory and neoplastic conditions. It is an empirical prescription composed of multiple herbs, with reported applications in diseases such as anaplastic thyroid cancer (ATC) and ruptured plasma cell mastitis. The decoction's mechanism of action is believed to be multi-targeted, involving anti-inflammatory, antitumor, immune-modulating, and detoxifying effects. Studies have identified active compounds within the formula—such as Saikosaponin A—that may exert antitumor activity by modulating molecular pathways relevant to cancer progression[1][3]. The precise composition can vary but typically includes herbs aimed at clearing heat and toxins, dispersing nodules or masses ("sanjie"), promoting blood circulation, and supporting immune function according to TCM theory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoyong sanjie decoction.